We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$208K
Cap. Flow
+$2.42M
Cap. Flow %
1.71%
Top 10 Hldgs %
51.56%
Holding
51
New
6
Increased
20
Reduced
15
Closed
5

Top Buys

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$2.43M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$2.39M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$2.29M
4
BPMC
Blueprint Medicines
BPMC
+$2.27M
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$2.27M

Top Sells

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$2.75M
2
ARGX icon
argenx
ARGX
+$2.35M
3
ATNX
Athenex, Inc. Common Stock
ATNX
+$2.31M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$2.21M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 50.39%
2 Financials 32.94%
3 Consumer Discretionary 8.74%
4 Industrials 2.71%
5 Real Estate 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARNA
51
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-47,779
Closed -$2.14M
1 2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q2 2019 Portfolio in Review

As of Q2 2019, Emory University held 51 positions worth $142M, down 0.15% from $142M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Emory University's Q2 2019 filing shows 6 new, 20 increased, 15 reduced and 5 closed positions. Its largest new stake was Array Biopharma Inc: 86,567 shares worth $4.01M. The largest sale was Solid Biosciences, an estimated $2.75M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 53% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emory University's largest Q2 2019 buy was Array Biopharma Inc: 86,567 shares worth $4.01M.
  • Emory University added most to BioCryst Pharmaceuticals in Q2 2019, an estimated $2.29M increase.
  • Emory University's biggest Q2 2019 reduction was Ascendis Pharma A/S, cutting an estimated $1.69M.
  • Emory University fully exited Solid Biosciences in Q2 2019, selling an estimated $2.75M.
  • Emory University's ten largest holdings make up 52% of its $142M portfolio in Q2 2019.
  • Emory University opened 6 new positions and closed 5 in Q2 2019.
  • Emory University's portfolio value fell 0.15% quarter-over-quarter to $142M.

Based on Emory University's 13F filing for Q2 2019, filed 14 Aug 2019.